Dudediligence.

Canopy Growth Corporation

CGCNASDAQ · Medicinal Chemicals & Botanical Products
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$63.0MSep ’24$74.8MDec ’24$65.0MMar ’25$72.1MJun ’25$66.7MSep ’25$74.5MDec ’25$71.2MMar ’26
Net income, by quarter
−$109.0MSep ’24−$98.1MDec ’24−$196.0MMar ’25−$44.9MJun ’25−$5.0MSep ’25−$58.3MDec ’25−$80.8MMar ’26
Fiscal years, by the month each ended
LineMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue$475.7M$333.3M$297.1M$269.0M$284.6M
Gross profit−$187.4M−$63.5M$80.9M$79.5M$69.7M
Operating income−$1.02B−$2.63B−$228.7M−$117.1M−$161.7M
Net income−$310.0M−$3.28B−$693.7M−$508.9M−$189.0M
Operating cash flow−$545.8M−$557.5M−$281.9M−$165.8M−$63.8M
Free cash flow−$582.5M−$566.7M−$285.4M−$176.6M−$69.1M
Cash$776.0M$667.7M$170.3M$113.8M$364.7M
Debt$1.50B$1.31B$597.2M$304.1M$233.4M
Shares outstanding394.4M51.7M91.1M183.9M422.1M